Oncternal Therapeutics: Q2 Earnings Snapshot
By AP News
Published - Aug 08, 2024, 05:01 PM ET
Last Updated - Aug 08, 2024, 05:01 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $8.6 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of $2.89.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $3.03 per share.
The biopharmaceutical company posted revenue of $801,000 in the period.
